In silico screening of alkaloids as potential inhibitors of epidermal growth factor receptor
Abstract
The epidermal growth factor receptor (EGFR) belongs to the HER/erbB receptor tyrosine kinase (RTK) family, serving as a crucial target for cancer treatment. Anti-EGFR drugs, used as a primary treatment for patients with advanced EGFR gene mutations such as T790M, C797S, and L858R, have shown greater efficacy and safety compared to standard chemotherapy...
điểm /
đánh giá
Published
2023-09-15
Section
LIFE SCIENCES